These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 24190862)

  • 21. The Wnt/β-catenin pathway in ovarian cancer: a review.
    Arend RC; Londoño-Joshi AI; Straughn JM; Buchsbaum DJ
    Gynecol Oncol; 2013 Dec; 131(3):772-9. PubMed ID: 24125749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A monoclonal antibody against the Wnt signaling inhibitor dickkopf-1 inhibits osteosarcoma metastasis in a preclinical model.
    Goldstein SD; Trucco M; Bautista Guzman W; Hayashi M; Loeb DM
    Oncotarget; 2016 Apr; 7(16):21114-23. PubMed ID: 27049730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of Wnt signaling activity for growth suppression induced by quercetin in 4T1 murine mammary cancer cells.
    Kim H; Seo EM; Sharma AR; Ganbold B; Park J; Sharma G; Kang YH; Song DK; Lee SS; Nam JS
    Int J Oncol; 2013 Oct; 43(4):1319-25. PubMed ID: 23900432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting Wnt/β-catenin signaling by microRNAs as a therapeutic approach in chemoresistant osteosarcoma.
    Hosseini F; Alemi F; Malakoti F; Mahmoodpoor A; Younesi S; Yousefi B; Asemi Z
    Biochem Pharmacol; 2021 Nov; 193():114758. PubMed ID: 34481813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aberrant activation of Wnt/β-catenin signaling drives proliferation of bone sarcoma cells.
    Chen C; Zhao M; Tian A; Zhang X; Yao Z; Ma X
    Oncotarget; 2015 Jul; 6(19):17570-83. PubMed ID: 25999350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 2-Methoxyestradiol-Mediated Induction of Frzb Contributes to Cell Death and Autophagy in MG63 Osteosarcoma Cells.
    Bravo D; Shogren KL; Zuo D; Wagner ER; Sarkar G; Yaszemski MJ; Maran A
    J Cell Biochem; 2017 Jun; 118(6):1497-1504. PubMed ID: 27883247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Redundant expression of canonical Wnt ligands in human breast cancer cell lines.
    Benhaj K; Akcali KC; Ozturk M
    Oncol Rep; 2006 Mar; 15(3):701-7. PubMed ID: 16465433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemical analyses of beta-catenin and cyclin D1 expression in giant cell tumor of bone (GCTB): a possible role of Wnt pathway in GCTB tumorigenesis.
    Matsubayashi S; Nakashima M; Kumagai K; Egashira M; Naruke Y; Kondo H; Hayashi T; Shindo H
    Pathol Res Pract; 2009; 205(9):626-33. PubMed ID: 19324500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Wnt1-induced MAFK expression promotes osteosarcoma cell proliferation.
    Wang R; Zheng J; Zhang DS; Yang YH; Zhao ZF
    Genet Mol Res; 2015 Jul; 14(3):7315-25. PubMed ID: 26214410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application of Long Noncoding RNAs in Osteosarcoma: Biomarkers and Therapeutic Targets.
    Li Z; Dou P; Liu T; He S
    Cell Physiol Biochem; 2017; 42(4):1407-1419. PubMed ID: 28715796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New avenues to target Wnt/β-catenin signaling.
    Verkaar F; Zaman GJ
    Drug Discov Today; 2011 Jan; 16(1-2):35-41. PubMed ID: 21111060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The potential of targeting Wnt/β-catenin in colon cancer.
    Sebio A; Kahn M; Lenz HJ
    Expert Opin Ther Targets; 2014 Jun; 18(6):611-5. PubMed ID: 24702624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting the Wnt/β-catenin signaling pathway in human cancers.
    Yao H; Ashihara E; Maekawa T
    Expert Opin Ther Targets; 2011 Jul; 15(7):873-87. PubMed ID: 21486121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Wnts, bone and cancer.
    Thomas DM
    J Pathol; 2010 Jan; 220(1):1-4. PubMed ID: 19890890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Wnt inhibitory factor 1 is epigenetically silenced in human osteosarcoma, and targeted disruption accelerates osteosarcomagenesis in mice.
    Kansara M; Tsang M; Kodjabachian L; Sims NA; Trivett MK; Ehrich M; Dobrovic A; Slavin J; Choong PF; Simmons PJ; Dawid IB; Thomas DM
    J Clin Invest; 2009 Apr; 119(4):837-51. PubMed ID: 19307728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The genetic basis for inactivation of Wnt pathway in human osteosarcoma.
    Du X; Yang J; Yang D; Tian W; Zhu Z
    BMC Cancer; 2014 Jun; 14():450. PubMed ID: 24942472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Wnt10b activates the Wnt, notch, and NFκB pathways in U2OS osteosarcoma cells.
    Mödder UI; Oursler MJ; Khosla S; Monroe DG
    J Cell Biochem; 2011 May; 112(5):1392-402. PubMed ID: 21321991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The overexpression of BAMBI and its involvement in the growth and invasion of human osteosarcoma cells.
    Zhou L; Park J; Jang KY; Park HS; Wagle S; Yang KH; Lee KB; Park BH; Kim JR
    Oncol Rep; 2013 Sep; 30(3):1315-22. PubMed ID: 23807684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Regulation of Wnt/β-catenin signaling in bone development and bone tumor].
    Zhou ZH; Xiao JR
    Zhonghua Wai Ke Za Zhi; 2018 Oct; 56(10):797-800. PubMed ID: 30369164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influencing the Wnt signaling pathway in multiple myeloma.
    Kim Y; Reifenberger G; Lu D; Endo T; Carson DA; Gast SM; Meschenmoser K; Nowak M; Schmidt-Wolf IG
    Anticancer Res; 2011 Feb; 31(2):725-30. PubMed ID: 21378363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.